- täglichErscheinungsrhythmus
- 21 mintypische Länge
- gesternletzte Folge
Folgenzu den neuesten
Insulin Analogs
Modern insulin pharmacokinetics are determined by molecular engineering targeting hexamer dissociation and systemic absorption kinetics. Rapid-acting formulations incorporate amino acid substitutions and excipients to accelerate hexamer-to-
Insulin Icodec
Insulin icodec, marketed as Awiqli, is a groundbreaking once-weekly basal insulin designed to simplify diabetes management by drastically reducing the number of required injections. Through its unique ability to bind to albumin, the medicat
FHH vs Normo-hormonal PHPT
Familial hypocalciuric hypercalcemia and normohormonal primary hyperparathyroidism present significant diagnostic overlap, both manifesting with hypercalcemia alongside inappropriately non-suppressed or normal intact parathyroid hormone lev
Everything about Cinacalcet
Cinacalcet is a positive allosteric modulator of the parathyroid calcium-sensing receptor (CaSR) indicated for hypercalcemia in primary hyperparathyroidism (PHPT) when parathyroidectomy is unfeasible. By enhancing receptor sensitivity to am
Oncocytic Thyroid Carcinoma
Oncocytic thyroid carcinoma, historically classified as a Hürthle cell variant of follicular carcinoma, represents a distinct clinical entity driven by mitochondrial DNA mutations and widespread chromosomal loss of heterozygosity. Pathologi
Glucocorticoid Induced Osteoporosis Management
Glucocorticoid-induced osteoporosis represents the most prevalent form of secondary bone loss, driven by rapid osteoblast apoptosis, suppressed bone formation, and transiently elevated osteoclast-mediated resorption. Skeletal deterioration
Osteoporosis treatment in CKD
PODCAST SUMMARY: Managing osteoporosis in chronic kidney disease requires navigating the overlap between osteopenia, osteoporosis, and CKD-metabolic bone disorder. DXA fails to differentiate osteoporosis from renal osteodystrophy sub-types
Molecular Testing in Indeterminate Thyroid Nodules
PODCAST SUMMARY: Fine-needle aspiration yields indeterminate cytopathology (Bethesda III/IV) in up to 30% of thyroid nodules, creating clinical management dilemmas between diagnostic hemithyroidectomy and conservative surveillance. Modern m
Preventing Rebound Fractures After Denosumab.
Denosumab withdrawal triggers a rapid rebound in bone remodeling, characterized by transient hyper-osteoclastogenesis, steep elevations in serum CTX/P1NP, and rapid loss of accumulated bone mineral density. This hyper-resorptive overshoot s
Post Menopausal Osteoporosis Management
Postmenopausal osteoporosis management mandates a risk-stratified approach prioritizing bone-forming anabolic agents—teriparatide, abaloparatide, or romosozumab—in patients at very high fracture risk before transitioning to antiresorptive c
Securing the Medicare Therapeutic Shoe Benefit
Qualifying high-risk diabetic patients for the Medicare Therapeutic Shoe Benefit requires strict documentation of systemic diabetic status alongside severe localized foot pathology, including peripheral neuropathy, partial or complete amput
Stopping the Acute Hypercalcemia Cascade
Acute hypercalcemic crisis represents a medical emergency driven by severe parathyroid hormone or calcitriol excess, osteolytic metastases, or PTHrP secretion, leading to profound natriuresis, intravascular volume depletion, and worsening r
The Endocrine Hijacking of Pregnancy
Gestational endocrinology involves a precise hormonal interplay where the placenta overrides maternal homeostatic baselines to prioritize fetal development. Placentally derived human chorionic gonadotropin, human placental lactogen, and pla
Thyroid Follicular Spectrum Lesions
Thyroid follicular spectrum lesions span a diagnostic continuum from benign adenomas and non-invasive follicular thyroid neoplasms with papillary-like nuclear features to invasive follicular carcinomas. Because fine-needle aspiration cytopa
Strategic Order of Osteoporosis Medications
Sequential therapy in osteoporosis requires precise mechanistic ordering because antiresorptives like bisphosphonates or denosumab blunt the bone-building efficacy of subsequent anabolic agents like teriparatide, abaloparatide, or romosozum
OSA and Tirzepatide
Obstructive sleep apnea drives a vicious metabolic cycle where intermittent nocturnal hypoxia and sleep fragmentation exacerbate systemic inflammation, oxidative stress, and insulin resistance. Weight loss remains the cornerstone of disease
DXA Interpretation and Pitfalls
Dual-energy X-ray absorptiometry measures areal bone mineral density (g/cm²) via soft tissue attenuation subtraction, rendering it susceptible to artifact-driven overestimation from lumbar degenerative sclerosis, aortic calcifications, and
AVS Case Walkthrough
Adrenal vein sampling remains the gold standard for lateralizing primary aldosteronism prior to adrenalectomy, particularly when cross-sectional imaging reveals bilateral normal glands or non-functioning incidentalomas. This case walkthroug
Post-surgical hypoparathyroidism
Post-surgical hypoparathyroidism remains the most frequent permanent complication following total thyroidectomy and central neck dissection, resulting from devascularization or inadvertent excision of the parathyroid glands. Management cent
NETest
The NETest is a multigene liquid biopsy measuring 51 circulating transcript profiles via RT-PCR and machine-learning algorithms to quantify neuroendocrine tumor activity on a 0 to 100 scale. Capturing programs like proliferation, somatostat
Osteoporosis: Treat to Target, Not Treat and Hope
The 2024 ASBMR and BHOF Task Force advocates a treat-to-target framework for osteoporosis management, using total hip bone mineral density T-score as the primary surrogate endpoint. For patients at imminent or very high fracture risk, initi
Methimazole discontinuation in Graves
Long-term methimazole continuation beyond the standard 12 to 18-month regimen addresses persistent autoimmune activation in high-risk Graves disease, where relapse rates exceed 70%. Thyrotropin-receptor antibody trajectories—classified as s
PTH and CaSR Receptor Kinetics
Parathyroid hormone (PTH) is an 84-amino acid peptide that maintains serum ionized calcium within a tight physiological range through an inverse sigmoidal feedback loop governed by the calcium-sensing receptor (CaSR) on chief cells. Secreti
Hungry bone syndrome
Hungry bone syndrome presents as severe, prolonged hypocalcemia following parathyroidectomy for primary or secondary hyperparathyroidism, driven by the abrupt withdrawal of elevated PTH and accelerated skeletal remineralization. Definitive
The Discovery of Insulin
This episode details the historic journey toward the discovery of insulin, transitioning from a period when a Type 1 diabetes diagnosis was an inevitable death sentence to a new era of medical management. It follows the collaborative yet of
The Life and Work of Jean-Martin Charcot
This podcast covers the influential career of Jean-Martin Charcot, the nineteenth-century physician who founded modern clinical neurology at the Salpêtrière hospital in Paris. By applying a rigorous anatomoclinical method, Charcot successfu
Hyperparathyroidism vs Idiopathic Hypercalciurea
This episode compares normocalcemic and hyperparathyroidism and idiopathic hypercalciuria, two primary drivers of hypercalciuria and nephrolithiasis. We contrast primary hyperparathyroidism, an autonomous parathyroid oversecretion causing e
Parathyroid Localization
This episode reviews the diagnostic strategies for parathyroid localization in primary hyperparathyroidism, guiding the practicing endocrinologist through the selection of optimal imaging modalities. We compare the utility of standard ultra
Diabetes ICD-10 Coding
This episode breaks down the intricacies of ICD-10 coding for type 2 diabetes mellitus, providing a practical framework for the practicing endocrinologist. We review the essential code structures under the E11 category, emphasizing the crit
